Hot flashes and night sweats (also called vasomotor symptoms or VMS) can be disruptive and have a negative effect on your quality of life. Sudden increases in body temperature, often accompanied by a red, flushed face and extreme sweating, can strike at any time of day and be uncomfortable. When they occur at night, they can disturb your quality of sleep, often leaving you feeling unsettled and tired
The Skylight Study is a clinical study evaluating the safety and effectiveness of a once-daily, nonhormonal investigational drug (fezolinetant) to see if it helps reduce the frequency and severity of hot flashes associated with menopause.
Current treatments for women experiencing menopausal hot flashes primarily consist of hormone replacement therapy and selective serotonin reuptake inhibitors (SSRIs). And, while many women have found some relief with these treatments, they can also be associated with unpleasant side effects and concerns about long-term side-effects. Therefore, there remains an unmet medical need for a different approach to managing these symptoms. By targeting the signals that affect the way your body regulates temperature, the investigational drug, fezolinetant, is designed to work in a way that is different from currently approved treatments.
If you are currently experiencing moderate to severe hot flashes associated with menopause, the Skylight Study might be an option for you.
You may qualify to participate if you:
- Are 40-65 years of age.
- Experiencing hot flashes associated with menopause.
If you are eligible and chose to participate, you will receive the following at no cost:
• All study-related drugs.
• Close care and monitoring from our team of medical professionals
Health insurance is not needed to participate.
To learn more about this study, or see if you may qualify, call 316-425-6333